Vascular Stent Market Size, Share, Trends, Growth Outlook

Vascular Stent Market is estimated to increase at a Compounded Annual Growth Rate of 7.4% CAGR over the forecast period from 2024 to 2030

The Vascular Stent Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), By Product (Bare-metal Stents, Drug-eluting Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), By Material (Metallic Stents, Cobalt Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Others), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Others).

An Introduction to Vascular Stent Market in 2024

Vascular stents are essential medical devices used to support and maintain the patency of narrowed or weakened blood vessels, thereby restoring blood flow and preventing complications such as thrombosis and restenosis. In 2024, the vascular stent market remains dynamic and competitive, driven by technological innovations, evolving clinical guidelines, and shifting patient demographics. From bare-metal and drug-eluting stents to bioresorbable and drug-coated scaffolds, a wide range of stent designs and materials are available to address diverse anatomical and pathological considerations. Advances in stent deployment techniques, imaging modalities, and surface modifications are enhancing procedural success rates, reducing adverse events, and improving long-term outcomes for patients with coronary artery disease, peripheral artery disease, and other vascular conditions. With an aging population and the increasing prevalence of cardiovascular risk factors, the demand for innovative vascular stent solutions is poised to grow, prompting continued investment in research, development, and regulatory efforts within the vascular intervention arena.

Market Trend: Advancements in Drug-Eluting Stent (DES) Technology

A prominent trend in the vascular stent market is the continuous advancements in drug-eluting stent (DES) technology. DESs are widely used in percutaneous coronary intervention (PCI) procedures to treat coronary artery disease (CAD) by preventing restenosis and reducing the risk of repeat revascularization. Recent developments in DES technology include the introduction of biodegradable polymers, novel drug coatings, and next-generation stent designs aimed at improving drug delivery, biocompatibility, and long-term clinical outcomes. Additionally, there is a growing emphasis on bioresorbable scaffolds and drug-free stents to address concerns related to long-term vessel healing and late thrombosis. As the demand for minimally invasive coronary interventions continues to rise, the evolution of DES technology drives market growth and fosters innovation in interventional cardiology.

Market Driver: Increasing Incidence of Cardiovascular Diseases and Aging Population

A key driver propelling the growth of the vascular stent market is the increasing incidence of cardiovascular diseases (CVDs) globally, coupled with the aging population. CVDs such as coronary artery disease (CAD), peripheral artery disease (PAD), and aortic aneurysms pose significant health burdens and are leading causes of morbidity and mortality worldwide. With changing lifestyles, rising prevalence of risk factors such as obesity, diabetes, and hypertension, and demographic shifts towards an aging population, there is a growing demand for effective treatments to manage and prevent CVDs. Vascular stents play a crucial role in restoring blood flow, relieving symptoms, and reducing the risk of adverse cardiovascular events in patients with obstructive arterial diseases. As healthcare providers prioritize early intervention and minimally invasive approaches in managing CVDs, the demand for vascular stents continues to escalate, driving market growth and innovation in interventional cardiology.

Market Opportunity: Expansion of Vascular Stent Applications and Indications

An emerging opportunity in the vascular stent market lies in the expansion of stent applications and indications beyond coronary arteries to address a broader range of vascular diseases and anatomies. While coronary stenting remains the primary application, there is growing interest in using vascular stents in peripheral arteries, carotid arteries, and complex lesions such as bifurcations and chronic total occlusions. Additionally, there is potential for stent technologies to be applied in non-atherosclerotic conditions such as venous diseases, vascular malformations, and congenital heart defects. By developing specialized stent platforms, drug delivery systems, and procedural techniques tailored to specific vascular indications, manufacturers can capitalize on this opportunity to diversify their product portfolios, address unmet clinical needs, and expand market reach in interventional vascular medicine.

Vascular Stent Market Share Analysis: Peripheral Stents is the fastest growing segment over the forecast period to 2030

The fastest-growing segment in the vascular stent market is Peripheral Stents, primarily due to technological innovations and a rising incidence of peripheral arterial diseases (PAD). Peripheral stents are utilized to treat blockages or narrowing in arteries outside the heart, commonly in the legs and arms. Factors such as an aging population, increasing prevalence of lifestyle-related diseases like diabetes and obesity, and advancements in stent design and materials have fueled the demand for peripheral stents. Additionally, the shift towards minimally invasive procedures and the development of drug-eluting and bioabsorbable stents have further contributed to the segment's rapid growth. As healthcare providers increasingly prioritize patient outcomes and cost-effective treatments, the adoption of peripheral stents is expected to continue accelerating, making it a key area of focus within the vascular stent market.

Vascular Stent Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp, Cook Medical Inc, Cordis Corp, Endologix Inc, EP Medsystems Inc, Fujifilm Corp, General Electric Company, Johnson & Johnson Inc, JOTEC GmbH, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd, Lombard Medical Technologies Inc, Medtronic PLC, Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corp, Nihon Kohden Corp, Osypka AG, Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Siemens Healthineers AG, Spectranetics Corp, Stentys SA, Stryker Corp, Terumo Corp, Translumina GmbH, W. L. Gore & Associates Inc, ZOLL Medical Corp

Vascular Stent Market Segmentation

By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Vascular Stent Market Companies

Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corp
Cook Medical Inc
Cordis Corp
Endologix Inc
EP Medsystems Inc
Fujifilm Corp
General Electric Company
Johnson & Johnson Inc
JOTEC GmbH
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co. Ltd
Lombard Medical Technologies Inc
Medtronic PLC
Meril Life Sciences Pvt. Ltd
MicroPort Scientific Corp
Nihon Kohden Corp
Osypka AG
Purple Medical Solution Pvt. Ltd
Sahajanand Medical Technologies Pvt. Ltd
Siemens Healthineers AG
Spectranetics Corp
Stentys SA
Stryker Corp
Terumo Corp
Translumina GmbH
W. L. Gore & Associates Inc
ZOLL Medical Corp

Reasons to Buy the Vascular Stent Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Vascular Stent Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Vascular Stent Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Vascular Stent Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Vascular Stent Market Size Outlook, $ Million, 2021 to 2030
3.2 Vascular Stent Market Outlook by Type, $ Million, 2021 to 2030
3.3 Vascular Stent Market Outlook by Product, $ Million, 2021 to 2030
3.4 Vascular Stent Market Outlook by Application, $ Million, 2021 to 2030
3.5 Vascular Stent Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Vascular Stent Industry
4.2 Key Market Trends in Vascular Stent Industry
4.3 Potential Opportunities in Vascular Stent Industry
4.4 Key Challenges in Vascular Stent Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Vascular Stent Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Vascular Stent Market Outlook by Segments
7.1 Vascular Stent Market Outlook by Segments, $ Million, 2021- 2030
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

8 North America Vascular Stent Market Analysis and Outlook To 2030
8.1 Introduction to North America Vascular Stent Markets in 2024
8.2 North America Vascular Stent Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Vascular Stent Market size Outlook by Segments, 2021-2030
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

9 Europe Vascular Stent Market Analysis and Outlook To 2030
9.1 Introduction to Europe Vascular Stent Markets in 2024
9.2 Europe Vascular Stent Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Vascular Stent Market Size Outlook by Segments, 2021-2030
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

10 Asia Pacific Vascular Stent Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Vascular Stent Markets in 2024
10.2 Asia Pacific Vascular Stent Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Vascular Stent Market size Outlook by Segments, 2021-2030
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

11 South America Vascular Stent Market Analysis and Outlook To 2030
11.1 Introduction to South America Vascular Stent Markets in 2024
11.2 South America Vascular Stent Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Vascular Stent Market size Outlook by Segments, 2021-2030
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others
12 Middle East and Africa Vascular Stent Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Vascular Stent Markets in 2024
12.2 Middle East and Africa Vascular Stent Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Vascular Stent Market size Outlook by Segments, 2021-2030
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corp
Cook Medical Inc
Cordis Corp
Endologix Inc
EP Medsystems Inc
Fujifilm Corp
General Electric Company
Johnson & Johnson Inc
JOTEC GmbH
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co. Ltd
Lombard Medical Technologies Inc
Medtronic PLC
Meril Life Sciences Pvt. Ltd
MicroPort Scientific Corp
Nihon Kohden Corp
Osypka AG
Purple Medical Solution Pvt. Ltd
Sahajanand Medical Technologies Pvt. Ltd
Siemens Healthineers AG
Spectranetics Corp
Stentys SA
Stryker Corp
Terumo Corp
Translumina GmbH
W. L. Gore & Associates Inc
ZOLL Medical Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)